CEO Spotlight: Michael Forbes – Leading the Way in Future Health and Longevity 

Covid-19 Isn’t Over: Hospitalizations Ups, Vaccines Down and Cannabis Reducing Symptoms? 

The Hidden Epidemic in Your Pantry: Time for a Food Safety Revolution

Are you ready for AI in healthcare?

Unleashing the Potential of Psychedelic Lifestyle Products: Exploring Investment Opportunities

Biohacking: Unlocking the Future of Optimal Health

Emerging Biotech Breakthroughs: Promising Stocks in Medical Innovation

Unveiling the Upcoming Trends in Big Pharma Stocks for 2023: Key Players and Emerging Opportunities

Recent News

NewAmsterdam aces Phase 3 trial, but investors are skeptical

NewAms­ter­dam Phar­ma’s lead car­dio pro­gram obice­trapib passed an­oth­er Phase 3 tri­al, demon­strat­ing its abil­i­ty to low­er “bad cho­les­terol” in com­bi­na­tion

Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your

FDA updates label of 33-year-old cancer drug with new dose and warning

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Subscribe

* indicates required

Latest Pharma News

NewAmsterdam aces Phase 3 trial, but investors are skeptical

NewAms­ter­dam Phar­ma’s lead car­dio pro­gram obice­trapib passed an­oth­er Phase 3 tri­al, demon­strat­ing its abil­i­ty to low­er “bad cho­les­terol” in com­bi­na­tion

Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your

Latest Cannabis News

Michigan Cannabis Sales Growth Was Slow Again in October

Michigan cannabis sales for October fell from a year ago in September and they rose sequentially 0.6% in October. At $268.6 million,

Green Dragon dispensaries, grow facility to remain open after cash infusion – The Cannabist

In an unexpected turn, Green Dragon, one of the largest dispensary chains in Colorado, will keep its stores and grow

Latest biotech News

Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets – Biotech Investments

EQS-News: Cantourage Group SE / Key word(s): Development of Sales/Monthly Figures New Sales Record: Cantourage Group SE Reports EUR 5.5

Top Medicaid official says Republicans’ proposed reforms are ‘just plain bad policy’

Business of Health Care Reporter Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on

Latest Life Science News

Children’s Colorado earns prestigious cardiomyopathy recognition

Children’s Hospital Colorado (Children’s Colorado) has been named a Cardiomyopathy Center of Care by the Children’s Cardiomyopathy Foundation (CCF), a

Cigarette smoke can induce disordered oropharyngeal microbiota that aggravates flu severity

New research has shown that cigarette smoke can induce disordered oropharyngeal microbiota that aggravates the severity of influenza A virus

Latest psychedelics News

Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing | Psychedelic Invest

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced the favorable outcome of

Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation | Psychedelic Invest

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced an effective date for

videos